Novartis Ag (NVS) Long-Term Investments (2009 - 2026)

Novartis Ag has disclosed Long-Term Investments across 18 years of filings, most recently posting $69.0 million for Q2 2026.

• In Q2 2026, Long-Term Investments fell 25.0% year-over-year to $69.0 million; the TTM figure through Jun 2026 stood at $69.0 million (down 25.0% YoY), while the FY2025 annual figure was $98.0 million, down 17.65% from the prior year.
• Long-Term Investments came in at $69.0 million for Q2 2026 at Novartis Ag, down from $100.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $205.0 million in Q4 2023 to a low of $69.0 million in Q2 2026.
• Average Long-Term Investments over 5 years is $127.4 million, with a median of $116.5 million recorded in 2024.
• Year-over-year, Long-Term Investments plunged 98.46% in 2022 and surged 43.36% in 2023.
• Over 5 years, Long-Term Investments stood at $143.0 million in 2022, then surged by 43.36% to $205.0 million in 2023, then tumbled by 41.95% to $119.0 million in 2024, then declined by 17.65% to $98.0 million in 2025, then slipped by 29.59% to $69.0 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $69.0 million in Q2 2026, $100.0 million in Q1 2026, and $98.0 million in Q4 2025.